文献速递腹部泌尿生殖技术与安全CT

非增强腹盆腔CT扫描在乳腺癌患者随访中的诊断准确性

Diagnostic accuracy of non-contrast abdominopelvic computed tomography scans in follow-up of breast cancer patients.
PubMed 文献 · Br J Radiol · 2020-12-11

这项回顾性研究纳入1396例乳腺癌患者,A组895例无转移患者中145例出现160处转移,两名阅片者基于患者的敏感度分别为68.3%和53.8%;B组已知肝转移患者中,按RECIST标准评估肝转移治疗反应的准确率分别为70.8%和63.8%;作者结论认为NECT诊断性能不足,但可用于肾功能下降或碘对比剂过敏患者。

要点

  • NECT对骨转移敏感度较高(98.9%和95.9%),对肝转移敏感度较低(73.7%和68.4%)。
  • 按患者计算的新发转移诊断敏感度仅68.3%和53.8%,按病灶计算为89.4%和85.0%。
  • NECT评估肝转移治疗反应的准确率分别为70.8%和63.8%,作者认为性能不足。

关键影像表现/征象

  • A组145例患者共160处转移,两名阅片者按患者敏感度分别为68.3%和53.8%,按病灶敏感度分别为89.4%和85.0%。
  • 骨转移敏感度分别为98.9%和95.9%,肝转移敏感度分别为73.7%和68.4%。
  • B组按RECIST标准评估肝转移治疗反应的准确率,阅片者1为70.8%,阅片者2为63.8%。

诊断标准与关键数值

  • 新发转移诊断敏感度:按患者68.3%(阅片者1)和53.8%(阅片者2),按病灶89.4%(阅片者1)和85.0%(阅片者2)。
  • 骨转移敏感度98.9%(阅片者1)和95.9%(阅片者2);肝转移敏感度73.7%(阅片者1)和68.4%(阅片者2)。
  • 肝转移治疗反应评估采用RECIST标准,准确率70.8%(阅片者1)和63.8%(阅片者2)。

临床应用与阅片要点

  • 作者结论认为NECT诊断性能不足,但可将其用作肾功能下降或对碘对比剂过敏患者的随访方式。
  • 作者指出,当NECT可作为肾功能下降患者的随访方式时,应重视对比剂副作用风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the effectiveness of follow-up with non-enhanced CT (NECT) in patients with breast cancer.

METHODS: The present retrospective study included 1396 patients with breast cancer. Group A included patients with no metastasis to evaluate the diagnostic performance of NECT in detecting newly developed metastasis. Group B included patients with known hepatic metastasis to evaluate the accuracy of NECT for the assessment of hepatic metastasis.

RESULTS: Group A included 895 patients (mean age 52.8 years). Among them, 145 patients had 160 metastases. The per-patient sensitivities for diagnosing newly developed metastasis were 68.3 and 53.8% according to the two reviewers, while the per-lesion sensitivities were 89.4 and 85.0%. Sensitivities for bone metastasis were 98.9 and 95.9%, while sensitivities for hepatic metastasis were 73.7 and 68.4%. In group B, the accuracy of hepatic metastasis response evaluation according to the RECIST criteria was 70.8% for reviewer 1 and 63.8% for reviewer 2.

CONCLUSIONS: NECT showed inadequate diagnostic performance in detecting newly developed metastasis and in evaluating the response of hepatic metastasis. However, NECT can be utilized as a follow-up modality in patients with decreased renal function or hypersensitivity to iodinated contrast media.

ADVANCES IN KNOWLEDGE: The risk of side effects of contrast media should be considered as important when NECT can be utilized as a follow-up modality in decreased renal function patients.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Nam SY, Ahn SJ, Jang YR, et al. Diagnostic accuracy of non-contrast abdominopelvic computed tomography scans in follow-up of breast cancer patients. Br J Radiol. 2020. PMID: 33306919. doi:10.1259/bjr.20201087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。